Truist Securities Maintains Buy Rating for Intuitive Surgical: Here's What You Need To Know
Portfolio Pulse from Benzinga Insights
Truist Securities has reaffirmed its Buy rating on Intuitive Surgical (NASDAQ:ISRG) and increased its price target from $375.00 to $390.00. Despite a slight decline in share price over the last 24 hours, the new price target suggests a potential upside of 17.57% from the current price of $331.72. Intuitive Surgical is known for its da Vinci robotic surgical systems, with over 8,000 units installed globally.
December 22, 2023 | 5:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Truist Securities maintains a Buy rating on Intuitive Surgical and raises the price target to $390, indicating a potential 17.57% upside from the current price.
The reaffirmation of a Buy rating and an increased price target by Truist Securities is a strong positive signal for investors, suggesting confidence in Intuitive Surgical's growth potential. This could lead to increased investor interest and a potential rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100